Skip to content

SEEING THE EFFECT OF LEECH THERAPY ON DIABETIC WOUND

Clinical evaluation of jalauka avacharana in the management of dushta vrana with special reference to madhumehaj vrana

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052855
Enrollment
40
Registered
2023-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

None listed

Sponsors

VYDS AYURVEDA MAHAVIDHLAYA
Lead Sponsor
HEAD OF DEPARTMENT
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with clinical features of Dustha Vrana w.s.r. Madhumehaja Vrana (diabetic ulcer) will be included. 2. Patients of both sexes between 25 to 60 years of age will be included in the study. 3. Patients with Fasting blood sugar level ranging between 70-130mg/dl and random blood sugar level ranging between 70-150 mg/dl will be included. 4.Patients with Hb level ranging between 10-16g/dl will be included. 5. Patients willing to give a consent to perform the therapy will be included. 6.Patients with bleeding time ranging between 2-9 min and clotting time between 10-13 sec will be included. 7.Patients with ulcer size less than or equal to 6cm from the widest dimension of the ulcer will be included.

Exclusion criteria

Exclusion criteria: 1.Patients with Hb level below 10g/dl will be excluded. 2. Patients with acute features and with complications like gangrene will be excluded. 3. Patients with peripheral vascular diseases like Raynaudâ??s disease, Buergerâ??s disease, DVT and Arterial and Venous ulcers will be excluded. 4. Patients associated with any other systemic diseases and HIV, HBsAg, HCV, VDRL will be excluded. 5. Patients with ulcer size more than 6cm will be excluded.

Design outcomes

Primary

MeasureTime frame
1. Size of ulcer 2. Discharge from the ulcer 3. Time taken for healingTimepoint: Weekly intervals, i.e 1 st week , 2nd week , 3rd week and 4th week.

Secondary

MeasureTime frame
smell , pain, and granulationsTimepoint: Weekly intervals, i.e 1st week , 2nd week , 3 rd week and 4th week.

Countries

India

Contacts

Public ContactDr Shubham Sharma

VAIDYA YAGYADUTT SHARMA AYURVED MAHAVIDHALAYA , KHURJA, DISTT BULANDSHAHR, UTTAR PARDESH .

dramitkjjftp@gmail.com9838325000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026